Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies
- Alternative title
-
Validierung und Charakterisierung von monoklonalen Antikörpern zur zielgerichteten Behandlung von Krebsstammzellen und zur Entwicklung neuer Krebstherapien
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2022
- Keyword
-
Cancer
Stem cells
Monoclonal antibodies
- Event
-
Veröffentlichung
- (where)
-
Darmstadt
- (who)
-
Universitäts- und Landesbibliothek
- (when)
-
2022
- Creator
- Contributor
- DOI
-
10.26083/tuprints-00021677
- URN
-
urn:nbn:de:tuda-tuprints-216776
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Müller, Sandra Rita
- Kolmar, Harald
- Breuhahn, Kai
- Universitäts- und Landesbibliothek
Time of origin
- 2022
Other Objects (12)
Cancer and anticancer : a discussion
Progress in anti-cancer chemotherapy
Targeting CDK9 for anti-cancer therapeutics
Inhibition of heme oxygenase-1 (HO-1) increases responsiveness of pancreatic cancer cells to anti-cancer treatment
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Iridium compounds as prospective anti-cancer agents
Progress in anti-cancer chemotherapy, Vol. 4
Molecular aspects of anti-cancer drug action
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Cancer and anticancer : a discussion
Progress in anti-cancer chemotherapy
Targeting CDK9 for anti-cancer therapeutics
Inhibition of heme oxygenase-1 (HO-1) increases responsiveness of pancreatic cancer cells to anti-cancer treatment
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Iridium compounds as prospective anti-cancer agents
Progress in anti-cancer chemotherapy, Vol. 4
Molecular aspects of anti-cancer drug action
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Cancer and anticancer : a discussion
Progress in anti-cancer chemotherapy
Targeting CDK9 for anti-cancer therapeutics
Inhibition of heme oxygenase-1 (HO-1) increases responsiveness of pancreatic cancer cells to anti-cancer treatment
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Dissecting population and single-cell heterogeneity in response to anti-cancer drugs
Iridium compounds as prospective anti-cancer agents
Progress in anti-cancer chemotherapy, Vol. 4
Molecular aspects of anti-cancer drug action
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Assessing the economic value of anti-cancer therapies